Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRAMETINIB DIMETHYL SULFOXIDE Cause Dry eye? 54 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Dry eye have been filed in association with TRAMETINIB DIMETHYL SULFOXIDE (Mekinist). This represents 0.3% of all adverse event reports for TRAMETINIB DIMETHYL SULFOXIDE.

54
Reports of Dry eye with TRAMETINIB DIMETHYL SULFOXIDE
0.3%
of all TRAMETINIB DIMETHYL SULFOXIDE reports
0
Deaths
7
Hospitalizations

How Dangerous Is Dry eye From TRAMETINIB DIMETHYL SULFOXIDE?

Of the 54 reports, 7 (13.0%) required hospitalization, and 2 (3.7%) were considered life-threatening.

Is Dry eye Listed in the Official Label?

Yes, Dry eye is listed as a known adverse reaction in the official FDA drug label for TRAMETINIB DIMETHYL SULFOXIDE.

What Other Side Effects Does TRAMETINIB DIMETHYL SULFOXIDE Cause?

Death (2,998) Pyrexia (2,660) Rash (1,271) Fatigue (1,143) Malignant neoplasm progression (1,114) Nausea (1,085) Chills (965) Diarrhoea (867) Vomiting (720) Product use in unapproved indication (687)

What Other Drugs Cause Dry eye?

DUPILUMAB (10,892) CYCLOSPORINE (1,310) ADALIMUMAB (1,253) METHOTREXATE (1,023) LIFITEGRAST (1,013) ETANERCEPT (992) TOFACITINIB (756) LENALIDOMIDE (649) TOCILIZUMAB (565) CENEGERMIN-BKBJ (537)

Which TRAMETINIB DIMETHYL SULFOXIDE Alternatives Have Lower Dry eye Risk?

TRAMETINIB DIMETHYL SULFOXIDE vs TRANDOLAPRIL TRAMETINIB DIMETHYL SULFOXIDE vs TRANDOLAPRIL\VERAPAMIL TRAMETINIB DIMETHYL SULFOXIDE vs TRANEXAMIC ACID TRAMETINIB DIMETHYL SULFOXIDE vs TRANYLCYPROMINE TRAMETINIB DIMETHYL SULFOXIDE vs TRASTUZUMAB

Related Pages

TRAMETINIB DIMETHYL SULFOXIDE Full Profile All Dry eye Reports All Drugs Causing Dry eye TRAMETINIB DIMETHYL SULFOXIDE Demographics